BIONATURIS GROUP Press releases


25 April 2017
Bionaturis out-licenses its Leishmaniasis vaccine for Argentina and Paraguay BIONATURIS GROUP
Bionaturis has signed an exclusive development, manufacturing, registration, and commercialization license of its Leishmaniasis vaccine with the company Biotandil for Argentina and Paraguay
According to the terms of the license, Bionaturis will receive 50% of the profits resulting of the commercialization.
  View more
14 December 2016
Bionaturis strengthens actions for reducing the use of antibiotics in porcine industry BIONATURIS GROUP
Bionaturis strengthens actions for reducing the use of antibiotics in porcine industry The biotechnological company takes part in the PROVACIN consortium, joined by partners Piensos Jimenez –leaders of the project- and Iberico Comercializacion (IBERCOM), with the main goal of reducing the use of antibiotics in white and iberian pigs
  View more
3 May 2016
Bionaturis Group grows through the acquisition of the company ZIP Solutions BIONATURIS GROUP
Zera Intein Protein Solutions (ZIP) is specialized in the development of technologies for the production of peptides and recombinant proteins
Previous to the acquisition, ZIP and a multinational company signed a co-development and a worldwide exclusive license for Splittera®
  View more
25 January 2016
Biobide signs a contract with the U.S. National Institute of Environmental Health Sciences (NIH-NIEHS) BIONATURIS GROUP
This project will analyze the toxicological impact of exposure to 30 chemical compounds using zebrafish as animal model.
The NIEHS is one of the 27 Institutes and Centers composing the US-National Institutes of Health.
  View more
12 January 2016
Bionaturis Group takes part in the development of a vaccine against cervical cancer BIONATURIS GROUP
The Centre for the Development of Industrial Technology (CDTI, in Spanish) has granted an incentive of 184.847,40 Euros to the company from the European Programme Eurostars
The project is led by the German company BioEnergy GmbH & Consultant with participation from the German Cancer Research Center
  View more
12 January 2016
Bionaturis Group takes part in the BIOMAP project BIONATURIS GROUP
BIOMAP is a consortium led by Laboratories Rovy that includes Vivacell Biotechnology Spain, Vaxdyn, and Bionaturis
The Feder-Interconecta Programme, via the Centre for the Development of Industrial Technology (CDTI, in Spanish), has granted Bionaturis 572.988€ for this biomedicine development initiative.
  View more
7 October 2015
Bionaturis unveils the development of six new biotech products BIONATURIS GROUP
Bionaturis unveils the development of six new biotech products -Five of these new drugs point to Animal Health sector that represents a $100 billion global annual worldwide market
-Broadening its portfolio Bionaturis Group strengthens its position as a reference partner to develop biological products for animal health from livestock to pets
  View more
21 December 2012
Bionaturis to tackle the vaccination system for fish farming with oral vaccines BIONATURIS GROUP
Bionaturis to tackle the vaccination system for fish farming with oral vaccines ? The AQUAFLY project, based on the Bionaturis FLYLIFE production system, will be deployed in collaboration with the Department of Chemical Engineering, Food Technology and Environmental Sciences, at the Science Faculty of Cadiz University; and CTAQUA (Andalusian Aquaculture Technological Centre Foundation).
  View more
16 October 2012
Bionaturis joins the “Targetfish” project BIONATURIS GROUP
Bionaturis joins the “Targetfish” project This project mainly seeks to develop new vaccines for aquaculture, with a focus on the species and fighting against the diseases with the greatest economic impact in the European Union.
  View more
26 January 2012
Bionaturis da la campanada BIONATURIS GROUP
Bionaturis da la campanada La empresa andaluza de biotecnología se incorpora al MAB
  View more
Developed by Web4Bio